MAPT and Alzheimer disease: Brain insulin resistance triggers a cascade of damage in AD by disrupting insulin signaling, leading to mitochondrial dysfunction, increased oxidative stress and neuroinflammation, which collectively promote tau hyperphosphorylation and Aβ accumulation, ultimately causing synaptic failure and neuronal death, and essentially making AD a “brain diabetes” [10].